Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Rigel PharmaceuticalsConcert PharmaceuticalsUrovant SciencesVerrica PharmaceuticalsSpectrum Pharmaceuticals
SymbolNASDAQ:RIGLNASDAQ:CNCENASDAQ:UROVNASDAQ:VRCANASDAQ:SPPI
Price Information
Current Price$1.89$9.01$11.67$12.00$2.92
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.52.21.11.51.5
Analysis Score3.53.43.53.53.3
Community Score2.82.72.12.32.8
Dividend Score0.00.00.00.00.0
Ownership Score1.04.00.01.01.0
Earnings & Valuation Score0.00.60.00.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$7.33$19.50$28.50$22.00$7.67
% Upside from Price Target288.01% upside116.43% upside144.22% upside83.33% upside162.56% upside
Trade Information
Market Cap$319.44 million$274.89 million$324.73 million$297.90 million$348.25 million
Beta1.280.931.452.382.06
Average Volume1,573,325115,61465,88161,4051,806,428
Sales & Book Value
Annual Revenue$59.29 million$1.08 millionN/AN/A$109.33 million
Price / Sales5.37247.36N/AN/A3.11
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.32 per share$4.26 per share$2.47 per share$2.52 per share$1.69 per share
Price / Book5.912.12N/AN/A1.73
Profitability
Net Income$-66,890,000.00$-78,170,000.00$-111,350,000.00$-28,210,000.00$-112,690,000.00
EPS($0.40)($3.29)($4.43)($1.13)($1.14)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-27.39%-97,236.70%N/AN/AN/A
Return on Equity (ROE)-40.15%-60.38%-351.07%-45.24%-62.98%
Return on Assets (ROA)-18.60%-47.76%-122.63%-38.17%-47.91%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.35%0.10%1.83%0.61%N/A
Current Ratio3.73%11.87%2.32%27.45%3.67%
Quick Ratio3.68%11.87%2.32%27.45%3.67%
Ownership Information
Institutional Ownership Percentage87.96%66.66%23.81%34.45%59.55%
Insider Ownership Percentage4.72%11.00%7.62%40.20%9.35%
Miscellaneous
Employees158711716235
Shares Outstanding168.57 million29.65 million30.52 million25.81 million116.47 million
Next Earnings Date8/4/2020 (Estimated)8/6/2020 (Estimated)6/11/2020 (Estimated)8/5/2020 (Estimated)8/13/2020 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.